Biotech News

Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite

Charles River (CRL)Charles River2026-09-08 12:00 ESTFDA / regulatory

Enhanced automation delivers improved traceability and capacity, while increasing manufacturing efficiency WILMINGTON, Mass. --(BUSINESS WIRE)--Sep. 8, 2026-- Charles River Laboratories International, Inc. (NYSE: CRL) has successfully implemented its Endosafe ® Cartridge Technology Automated

Charles River

Preclinical Research Services Charles River Laboratories provides products and outsourced services used by pharmaceutical, biotechnology, academic and government researchers across early drug development. Research Models and Services The company supplies research models and related services used in basic research, target validation and...

Recent company news

CRLCharles River2026-09-24 12:00 EST

Charles River Highlights Refreshed Strategic Vision to Drive Profitable Growth and Long-Term Value Creation at 2026 Investor Day

CRLCharles River2026-09-17 12:00 EST

Charles River Laboratories and Medigen Vaccine Biologics Corp Collaborate to Advance New Vaccine Development Programs Through Next Generation Sequencing

Stock data

Close: 290.19 USD
Market cap: 8.42B USD
Exchange: NYSE
Sector: Biopharma
Location: United States

Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite

Related news

Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise

Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions

Charles River

Recent company news

Charles River Highlights Refreshed Strategic Vision to Drive Profitable Growth and Long-Term Value Creation at 2026 Investor Day

Charles River Leverages Expertise in Rapid and In Vitro Methods to Reduce Cell Banking Timelines

Charles River Laboratories to Present at Morgan Stanley and Baird Conferences